CClinicalTrials.gg
Status unknownNCT01003509herniUpdated May 4, 2011

A New Approach in Inguinal Hernia Repair: Double Repair. A Prospective, Randomized, Controlled Clinical Trial

An interventional study of modified shouldice and double in Hernia, sponsored by SB Istanbul Education and Research Hospital. Status unknown at 1 site in Turkey. Open to participants aged 16 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-05-04.

Sponsored by SB Istanbul Education and Research Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2009), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
16 Years to 90 Years
Sex
All
01

Study summary

This is a new inguinal hernia repair technique.

Read the detailed description

In this study we are revealing a new inguinal hernia repair technique. It is constructed from two layers. Deep layer is modified Shouldice technique, the other superficial one is moloney technique.

02

Conditions studied

  • Hernia

Keywords

  • inguinal
  • hernia
  • new
  • repair
  • modified shouldice
  • double
03

In context

Hernia

1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.

This study's planned enrollment of 50 is below the median of 80 across 739 interventional studies indexed under Hernia.

Browse Hernia studies →

Lead sponsor

SB Istanbul Education and Research Hospital is the lead sponsor of 19 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Inguinal hernia

Exclusion criteria

Exclusion Criteria:

  • Recurrences, child
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
50 participants (estimated)

Study arms

  • No intervention
    study, control

    Control: Only modified shouldice repair performed Study: Modified Shouldice + Moloney repairs performed

  • No intervention
    modified shouldice and double

    one arm is only modified shouldice, other one is double

    Procedure: modified shouldice and double

Interventions

  • Proceduremodified shouldice and double

    one arm modified shouldice, other one is double repair

    Also known as: control group, study group

06

What researchers measure

Primary outcomes

  1. complications, recurrences

    Time frame: 6 month

07

Study locations

1 of 1 sites recruiting
  • S.B. Istanbul Educational & Teaching Hospital
    Istanbul, Marmara 34565, Turkey
    • Arslan Kaygusuz, surgeon · Contact · akaygusuz@yahoo.com · +902125884400
    • Ozgur yigit, surgeon · Contact · ozguryigit@gmail.com · +905884400
    • erhan aysan, assoc. prof. · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01003509
Lead sponsor
SB Istanbul Education and Research Hospital
First posted
Oct 28, 2009
Start date
Jan 2001
Primary completion
Jan 2006
Completion
Jan 2012 (estimated)
Last update
May 4, 2011

Study contacts

erhan mr aysan, assoc. prof.
Contact
dr@webcerrah.com
+902125884400
hasan mr bektas, surgeon
Contact
drhasanbektas@gmail.com
+902164356765
Arslan Kaygusuz, surgeon
study chair · S.B. Istanbul Educational & Teaching Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion